‹ All Posts
Mayank Kumar

3rd Mar 2025 · SEBI-Registered Analyst

AstraZen

ASTRAZEN
Received permission from the Central Drugs Standard Control Organisation to import lung cancer drug Stock is moving in a channel, as per the important channel stock at important resistance zone 7650 and support at 6000.

#StockInNews#Budget2025#WatchOutFor#Today’sTradingSetup#TechnicalViews
ASTRAZEN_2025-03-03_10-19-47.png
156 likes·68 comments